February 20, 2020: Former passengers of the Diamond Princess cruise ship board a Taxi to leave after spending weeks on board in quarantine due to fears of spreading the COVID-19 Coronavirus in Yokohama. (Photo by Stanislav Kogiku/SOPA Images/LightRocket via Getty Images)
Princess Cruises, which had one of its ships quarantined off the coast of Japan last month, is suspending global operations through early May because of the coronavirus pandemic.
The cruise line, which is part of Carnival Corp., said Thursday that 18 cruise ships will cease voyages that were scheduled to depart between March 12 and May 10.
Japanese authorities quarantined the Diamond Princess cruise ship off the port of Yokohama for a two weeks after 10 passengers were initially diagnosed with the COVID-19.
The Miami cruise operator said those currently on cruises that will end in the next five days will continue to sail as expected so that travel arrangements aren't disrupted. Sailings underway that extend past March 17 will end at the most convenient location for guests, factoring in operational requirements.
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
A group of Democratic Texas lawmakers is asking Elon Musk to delay his rollout of driverless ‘robotaxis’ in the state this weekend to assure the vehicles are safe enough.
The billionaire slated to takeover the controlling interest in the Los Angeles Lakers has built a career leading businesses investing in everything from sports franchises to artificial intelligence.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!